← Back to Search

Nutrition Support Program for Pancreatic Cancer

N/A
Recruiting
Led By Amir Alishahi Tabriz, MD, PhD, MPH
Research Sponsored by H. Lee Moffitt Cancer Center and Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Planning to initiate chemotherapy under the guidance of Moffitt
Newly diagnosed metastatic or newly recurrent pancreatic cancer or locally advanced pancreatic cancer
Must not have
Undergoing concurrent treatment for a second primary GI cancer
Presence of malignant ascites
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 90 days
Awards & highlights
No Placebo-Only Group

Summary

This trial assesses how well a program providing additional dietician access and nutrition support helps people living with pancreatic cancer receiving chemo.

Who is the study for?
This trial is for adults over 18 with new or returning pancreatic cancer who are starting chemotherapy. They must be able to understand and speak English, give informed consent, and not have any serious psychiatric issues or other GI cancers.
What is being tested?
The STRONG program's effectiveness is being tested. It includes a daily food diary app, questionnaires, and regular consultations with a dietician to support the nutrition of those undergoing chemo for pancreatic cancer.
What are the potential side effects?
There may not be direct side effects from the interventions as they involve nutritional guidance rather than medication. However, participants might experience stress or discomfort related to frequent monitoring of their diet.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I plan to start chemotherapy as advised by Moffitt.
Select...
I have been recently diagnosed with advanced or recurrent pancreatic cancer.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently being treated for another primary cancer in my digestive system.
Select...
I have fluid buildup due to cancer in my abdomen.
Select...
I need some help with my daily activities.
Select...
I have received chemotherapy for recurrent pancreatic cancer in the last 6 months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 90 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability of the STRONG Program
Feasibility of the STRONG Program
Malnutrition: Low BMI
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Group 2: Usual CareActive Control3 Interventions
Participants will be referred to dieticians based on clinical discretion. Participants will also be asked to wear a Fitbit for 12 weeks to passively collect data on activity level.
Group II: Group 1: STRONG InterventionActive Control3 Interventions
The STRONG program includes consultation with a Moffit dietician, logging intake of food daily into a food diary with a Fitbit smartphone app, and completing questionnaires.

Find a Location

Who is running the clinical trial?

Pancreatic Cancer Action NetworkOTHER
5 Previous Clinical Trials
9,882 Total Patients Enrolled
H. Lee Moffitt Cancer Center and Research InstituteLead Sponsor
567 Previous Clinical Trials
144,839 Total Patients Enrolled
Amir Alishahi Tabriz, MD, PhD, MPHPrincipal InvestigatorMoffitt Cancer Center
1 Previous Clinical Trials
10 Total Patients Enrolled
Pamela Hodul, MDPrincipal InvestigatorMoffitt Cancer Center
5 Previous Clinical Trials
159 Total Patients Enrolled
Kea Turner, PhDPrincipal InvestigatorMoffitt Cancer Center
3 Previous Clinical Trials
113 Total Patients Enrolled

Media Library

Group 2: Usual Care Clinical Trial Eligibility Overview. Trial Name: NCT05675059 — N/A
Pancreatic Cancer Research Study Groups: Group 2: Usual Care, Group 1: STRONG Intervention
Pancreatic Cancer Clinical Trial 2023: Group 2: Usual Care Highlights & Side Effects. Trial Name: NCT05675059 — N/A
Group 2: Usual Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT05675059 — N/A
~27 spots leftby Jan 2026